Rhythm Pharmaceuticals, Inc. announced that its 2025 annual meeting of stockholders will be held on June 24, 2025. Stockholders seeking to bring business before the meeting or nominate a director must submit their proposals by March 26, 2025. Proposals intended for inclusion in the company’s proxy statement must also be received by that date.

All submissions must comply with the company’s amended and restated bylaws, SEC regulations, and other applicable laws. Notices should be directed to the company’s Secretary at its Boston headquarters.